SCHEMBL6576127

SCHEMBL6576127

COc1c([N+](=O)[O-])ccc(Cl)c1COc1ccc2nc(C)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
ALDH1A1 P00352 5/20 0.37
MAPT P10636 3/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MERTK Q12866 1/20 0.36
LMNA P02545 2/20 0.35
HPGD P15428 2/20 0.35
RAF1 P04049 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578371 0.89 ALDH1A1 (0.44) S1PR4SMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6581385 0.89 TP53 (0.42) S1PR4SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6576231 0.84 MAPT (0.40) S1PR4SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6580686 0.84 S1PR4 (0.44) S1PR4SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6578780 0.82 NCF1 (0.40) CYP1A2CYP2D6ALDH1A1MAPTNPC1
SCHEMBL6580761 0.81 MAPT (0.42) S1PR4SMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6581453 0.80 ALDH1A1 (0.40) S1PR4SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6578500 0.79 ALDH1A1 (0.43) S1PR4SMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6576124 0.78 MEN1 (0.57) ALDH1A1KMT2A
SCHEMBL6581287 0.77 MAPT (0.42) S1PR4SMN1; SMN2CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed